Delivery Order SPE2DP24D0004-SPE2DP24F3313
- Not listed
- This federal contract award is for the delivery of flu vaccines by Seqirus USA Inc., a global biotechnology company, to various U.S. government agencies including the Department of Defense, Department of Veterans Affairs, Department of Health and Human Services, and Department of Justice. The contract, valued at $1,351,500.00, is a Firm Fixed Price Purchase Order with a completion date of July 7, 2019. The contract is not designated as a set-aside. Seqirus USA Inc. has been awarded numerous...
- The U.S. federal government has awarded a $141,185 delivery order contract to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The contract, with a performance period ending on August 30, 2024, is for the supply of influenza virus vaccines. Seqirus USA Inc. is the prime contractor and will be delivering the vaccines under this firm-fixed-price contract. This award is not associated with a set-aside program. Seqirus USA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $179,917.20 contract is for the delivery of influenza virus vaccines to support immunization programs for military personnel. Seqirus USA Inc., through its Seqirus USA, Inc. Division, has provided influenza vaccines to various federal government customers including the Department of Veterans...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the provision of influenza virus vaccines. The contract, valued at $12,072,680.00, has an ultimate completion date of October 13, 2023. Seqirus USA Inc. is a global leader in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The company holds several...
- This is a $10,091,030 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc. for the delivery of influenza virus vaccines. The contract has a period of performance through September 27, 2024. Seqirus is a global biotechnology company that specializes in the development and delivery of influenza vaccines. The company has been awarded numerous federal contracts and delivery orders to provide influenza vaccines to various...
- This federal contract award was issued by the Department of Health and Human Services (HHS) to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $940,522.50 firm fixed price purchase order is for the delivery of flu vaccines. Seqirus USA Inc. has previously received awards from other federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Centers for Disease Control and...
- This is a delivery order awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccine development and delivery. The order, valued at $9,597,690.00, is for the supply of influenza virus vaccines. Seqirus USA Inc. has been awarded multiple federal contracts and task orders to provide influenza vaccines to various government healthcare programs and agencies, including the Department of Veterans Affairs,...
- This federal contract award, identified as SPE2DP16D0005|0001, is for the delivery of influenza virus vaccines. The contract was awarded to Seqirus USA Inc., a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The contract is a firm-fixed-price delivery order with a ceiling value of $10,003,042.50 and a performance period ending on September 30, 2016. The contract was awarded by the...
- This federal contract award to Seqirus USA Inc. is for the delivery of flu vaccines. The $1,241,993.00 fixed-price purchase order was awarded on June 30, 2020 by the U.S. Department of Health and Human Services and has a completion date of July 30, 2020. Seqirus is a global biotechnology company that specializes in the manufacturing and delivery of influenza vaccines to various federal government agencies. The company has been awarded multiple Indefinite Delivery Contracts (IDCs) with agencies...
- This federal contract award, SPE2DP16M0735, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The $124,772.50 firm-fixed-price purchase order is for the delivery of influenza virus vaccines, with an ultimate completion date of October 3, 2016. The contract does not have a set-aside designation. Seqirus USA Inc., through its Seqirus Usa, Inc. division, is known for producing a...
- SPE2DP24D0004Indefinite Delivery Contract
- SPE2DP24D0004-SPE2DP24F3313Delivery Order
This federal contract award, valued at $1,754,655.00, was issued by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccine development and production. The contract is a Delivery Order under a broader Indefinite Delivery Indefinite Quantity (IDIQ) contract, with a firm fixed price pricing type and an ultimate completion date of September 27, 2024. Seqirus USA Inc. has been awarded numerous federal contracts to provide influenza virus vaccines to various government agencies, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and Department of Health and Human Services. These contracts support the government's efforts to maintain military readiness, protect veterans, provide healthcare services for federal inmates, and immunize pediatric, adult, and elderly populations through programs administered by the Indian Health Service, Centers for Disease Control and Prevention, and National Institutes of Health. The contract award does not include a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8m | 3/19/24 |